transitioning from tirzepatide to retatrutide Switching Retatrutide: The Complete Transition Guide | PeptIQ Blog Retatrutide vs Tirzepatide vs Semaglutide

Current FDA-approved treatment options for BED are limited

At an expected price in the $1,200 to $1,500 per month range, US insurance plans are going to push back

A cross-sectional survey of 3035 patients with fibromyalgia: subgroups of patients with typical comorbidities and sensory symptom profiles

Fastest results come from pairing the medication with consistent protein intake (0.71g per lb of target weight), strength training 23x/week, and 78 hours of sleep

Whether this unique pattern worsens the obese state or constitutes a favorable adaptation remains unclear, and the physiological and pathophysiological implications of the altered GH/IGF-I axis in obesity remain uncertain with GH neither being the cause nor the solution to reverse obesity